Mendelian susceptibility to mycobacterial disease

Respiration

Volumn 73, Issue 3, 2006, Pages 280-282

  Kumararatne, Dinakantha S ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR 1; GAMMA INTERFERON RECEPTOR 2; INTERLEUKIN 12; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 23; STAT1 PROTEIN; T6 ANTIGEN; UNCLASSIFIED DRUG;

DISEASE PREDISPOSITION; EDITORIAL; FATALITY; GENE DELETION; GENE EXPRESSION; GENE MUTATION; HISTIOCYTOSIS X; HOMOZYGOSITY; HUMAN; IMMUNE RESPONSE; MISSENSE MUTATION; MYCOBACTERIOSIS; MYCOBACTERIUM; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RELAPSE; SIGNAL TRANSDUCTION;

ADULT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MUTATION; MYCOBACTERIUM INFECTIONS; RECEPTORS, INTERFERON; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12;

EID: 33646537769     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000092083     Document Type: Editorial

References (24)

1. Kumararatne DS: Tuberculosis and immunodeficiency - of mice and men. Clin Exp Immunol 1997;107:11-14.
2. Casanova JL, et al: Immunological conditions of children with BCG disseminated infection. Lancet 1995;346:581.
3. Van de Vosse E, Hoeve MA, Ottenhoff TH: Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 2004;4:739-749.
4. Casanova JL, Abel L: Genetic dissection of immunity to mycobacteria: the human model. Annu Rev Immunol 2002;20:581-620.
5. Remiszewski P, Roszkowska-Śliż B, Winek J, Chapgier A, Feinberg J, Langfort R, Bestry I, Augustynowicz-Kopeć E, Ptak J, Casanova JL, Rowińska-Zakrzewska E: Disseminated Mycobacterium avium infection in a 20-year-old female with partial recessive IFNγR1 deficiency. Respiration 2006;73:375-378.
6. Jouanguy E, et al: Partial interferon-γ receptor-1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis. J Clin Invest 1997;100:2658-2664.
7. Rosenzweig SD, et al: A novel mutation in IFN-γ receptor-2 with dominant negative activity: biological consequences of homozygous and heterozygous states. J Immunol 2004;173:4000-4008.
8. Dorman SE, Holland SM: Mutation in the signal-transducing chain of the interferon-γ receptor and susceptibility to mycobacterial infection. J Clin Invest 1998;101:2364-2369.
9. Döffinger R, et al: Partial interferon-γ receptor signaling chain deficiency in a patient with bacille Calmette-Guérin and Mycobacterium abscessus infection. J Infect Dis 2000;181:379-384.
10. Altare F, et al: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998;280:1432-1435.
11. De Jong R, et al: Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998;280:1435-1438.
12. 1 deficiency. Eur J Immunol 2003;33:3393-3397.
13. 1 deficiency: medical and immunological implications. J Exp Med 2003;197:527-535.
14. Altare F, et al: Inherited interleukin-12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest 1998;102:2035-2040.
15. Dupuis S, et al: Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001;293:300-303.
16. Dupuis S, et al: Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nat Genet 2003;33:388-391.
17. Döffinger R, et al: Autoantibodies to interferon-γ in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity. Clin Infect Dis 2004;38:10-14.
18. Dorman SE, et al: Clinical features of dominant and recessive interferon-γ receptor-1 deficiencies. Lancet 2004;364:2113-2121.
19. Picard C, et al: Inherited interleukin-12 deficiency: IL-12B genotype and clinical phenotype of 13 patients from six kindreds. Am J Hum Genet 2002;70:336-348.
20. Lammas DA, et al: Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin-12-dependent interferon-γ production pathway. Int J Exp Pathol 2002;83:1-20.
21. MacLennan C, et al: Interleukin (IL)-12 and IL-23 are key cytokines for immunity against Salmonella in humans. J Infect Dis 2004;190:1755-1757.
22. Edgar JD, et al: Interferon-γ receptor deficiency mimicking Langerhans' cell histiocytosis. J Pediatr 2001;139:600-603.
23. Holland SM, et al: Treatment of refractory disseminated nontuberculous mycobacterial infection with interferon-γ. A preliminary report. N Engl J Med 1994;330:1348-1355.
24. Jouanguy E, et al: A human IFNγR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999;21:370-378.